跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NAT-OSELTAMIVIR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
NAT-OSELTAMIVIR
Authorized
STANDARD
NAT-OSELTAMIVIR
natco pharma (canada) inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
3df43c3ff5432db2
Company
natco pharma (canada) inc
Type
Standard
Approval Details
Approval Id
3df43c3ff5432db2
Drug Approval Canada Name
NAT-OSELTAMIVIR
Product Name
NAT-OSELTAMIVIR
Status
Marketed
Status Date
2020-09-29
Original Market Date
2020-09-29
Din
02499894
Drug Class
Human
Dosage Form
Powder For Suspension
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:18.28
Atc Original
J05AH02 OSELTAMIVIR
Atc Name
j 05 ah 02
Aig Number
0139501005
Company Name
natco pharma (canada) inc
Company Address
2000 Argentia Road, Plaza 1, Suite 200, Mississauga, Ontario, Canada, L5N 1P7
Active Ingredients
OSELTAMIVIR (OSELTAMIVIR PHOSPHATE)
6 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
3df43c3ff5432db2
Type
Standard
Back to Health Canada Approvals